Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yuchuang Film is a hospital-developed topical medication (hospital preparation) created by Beijing Shijitan Hospital, affiliated with Capital Medical University, specifically for the treatment of recurrent oral ulcers (ROU). It is a composite film formulation that typically combines anti-inflammatory, antimicrobial, and nutritional agents. The preparation works by forming a thin, protective physical barrier over the ulcerated oral mucosa, which shields the sensitive area from external stimuli (such as food and saliva) while providing localized delivery of its active ingredients. The standard formulation includes dexamethasone to suppress local immune responses and inflammation, metronidazole to prevent secondary anaerobic bacterial infections, and riboflavin (Vitamin B2) to promote mucosal tissue repair and regeneration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yuchuang film.